Prostatic Diseases Clinical Trial
— HYPNOTICOfficial title:
Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging
The prostatic biopsies echo-guided are a painful and stressful. The purpose is to test a new medical device created recently, " Hypnos-Pro ", wich uses connected technologies. This connected device is a mask with diodes coupled with an audio headset and a touch pad. This connected mask is an another option to induce an hypnotic state for our patients. the objective is to value hypnotic mask effectiveness, to reduce the level pain and anxiety for the patients who benefit a prostatic biopsies echo-guided with local anesthesia.
Status | Recruiting |
Enrollment | 172 |
Est. completion date | December 2021 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 50 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Patient eligible for prostate biopsies - Having accepted and signed the consent, for performing a prostate biopsy ultrasound examination - No contraindication to the gesture - Supporting the left lateral decubitus Exclusion Criteria: - Patient isolation contact / droplets - Patient with hearing and / or epilepticus and / or dementia and / or having a history of stroke and / or allergic to lidocaine - Person unable to consent, or benefiting from a system of legal protection (tutelage / curatorship). - Patients with epileptic seizures. - Patients with known allergies to plastics and other resins that may develop allergic contact dermatitis. - Patients who are hypersensitive to radio frequency. - Patients with Rocephin administration before the gesture |
Country | Name | City | State |
---|---|---|---|
France | Hôpital Claude Huriez, CHU | Lille |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Lille |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual analogic Scale | Measure the pain in the scale from 0 to 10 | at 20 minutes after the removal of the probe | |
Secondary | State-Trait Anxiety Inventory ou STAI forme Y-A | Baseline, at 20 minutes after the removal of the probe | ||
Secondary | Percentage of positive response of satisfaction of the patient | The question is: Would you do prostate biopsy punctures under the same conditions in a month? (Yes: effective method, No: ineffective method). | at 20 minutes after the removal of the probe | |
Secondary | Percentage of positive response of satisfaction of the operator | The question is: In your opinion, has the gesture been made optimally? (Yes/ No). | at 20 minutes after the removal of the probe |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00941343 -
Benign Prostatic Hyperplasia in Taiwan
|
N/A | |
Completed |
NCT00575913 -
Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study
|
Phase 4 | |
Completed |
NCT02074644 -
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
|
N/A | |
Active, not recruiting |
NCT03344757 -
Health Gatherings - For Your Health After Cancer
|
N/A | |
Terminated |
NCT02606123 -
Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02245334 -
A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
|
Phase 4 | |
Active, not recruiting |
NCT01464216 -
MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
|
||
Not yet recruiting |
NCT05574647 -
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer
|
N/A | |
Completed |
NCT03192917 -
Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy
|
N/A | |
Completed |
NCT03104907 -
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer
|
N/A | |
Completed |
NCT03099421 -
Prostatic Artery Embolization for Benign Prostatic Obstruction
|
N/A | |
Completed |
NCT00853710 -
Test Semiquantitative Prostate Specific Antigen (PSA)
|
N/A | |
Completed |
NCT01316458 -
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
|
Phase 2 | |
Recruiting |
NCT05413850 -
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
|
Phase 1/Phase 2 | |
Completed |
NCT05941260 -
Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
|
||
Terminated |
NCT02031029 -
Character Traits and Stress in Suspected Prostate Cancer
|
N/A | |
Completed |
NCT00484783 -
Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery
|
N/A | |
Terminated |
NCT00672009 -
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
|
Phase 2 | |
Approved for marketing |
NCT04452136 -
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer
|